Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.

BACK TO LIST

Patient
Name:	Varela, Rosario
DOB:	03-MAY-1956 (Age: 69)
Gender:	male
Address:	Ronda de Graciela Llorens 62 46001 Valencia (Spain)
ID:	8295-992682-3 (ECI)

Report
Date:	18-DEC-2022

Laboratory
dr Ample, Ex Laboratoire Central Européenne Boulevard du Jardin Botanique 32 1000 Brussels (Belgium)

Requested by
Centro Privado de Educación Especial Parálisis Cerebral Infantil Calle Alboraya 4 46010 Valencia (Spain)

Specimen
Collected:	18-DEC-2022

Chemistry

Test	18-DEC-2022	Reference Range	Unit
Glucose [Mass/volume] in Blood	87.5	70 - 100	mg/dL
Urea nitrogen [Mass/volume] in Blood	14.6	7 - 18	mg/dL
Creatinine [Mass/volume] in Blood	2.5 H	0.6 - 1.3	mg/dL
Calcium [Mass/volume] in Blood	8.8	8.5 - 10.5	mg/dL
Sodium [Moles/volume] in Blood	137.6	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	4.6	3.5 - 5.1	mmol/L
Chloride [Moles/volume] in Blood	106.0	98 - 107	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	25.5	22 - 29	mmol/L
Protein [Mass/volume] in Serum or Plasma	7.2	6.6 - 8.3	g/dL
Albumin [Mass/volume] in Serum or Plasma	4.1	3.5 - 5.5	g/dL
Globulin [Mass/volume] in Serum by calculation	2.7 L	20 - 39	g/L
Bilirubin.total [Mass/volume] in Serum or Plasma	0.4	0.2 - 1.2	mg/dL
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma	79.5	39 - 117	U/L
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma	53.0 H	10 - 40	U/L
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma	33.2	10 - 40	U/L
Cholesterol [Mass/volume] in Serum or Plasma	200.1 H	125 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	115.5	0 - 150	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	114.1 H	0 - 100	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	30.8 L	40 - 60	mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows elevated creatinine, suggesting impaired renal function, and mildly increased ALT, indicating possible liver involvement. Lipid profile reveals high total and LDL cholesterol with low HDL, increasing cardiovascular risk. Globulin is low, which may reflect protein synthesis or immune issues. Other parameters are within normal limits. Recommend further evaluation of renal and liver function and management of dyslipidemia.

Conclusion and Recommendations based on this report and previous findings known to us

The patient shows elevated creatinine, suggesting impaired renal function, and mildly increased ALT, indicating possible liver involvement. Lipid profile reveals high total and LDL cholesterol with low HDL, increasing cardiovascular risk. Globulin is low, which may reflect protein synthesis or immune issues. Other parameters are within normal limits. Recommend further evaluation of renal and liver function and management of dyslipidemia.